Jiaxing Hengjie Biopharmaceutical Co., Ltd.
Similar suppliers you may like
Jiaxing Keying Intelligent Technology Co., Ltd.
🇨🇳 China
202211-50 peopleManufacturer/Service CompanyHigh-tech enterprise
Own brand
Low MOQ
Description
Jiaxing Keying Intelligent Technology Co., Ltd. is a high-tech enterprise based in Jiaxing, China, specializing in the research, development, production, and sales of high-end equipment and cell engineering technology for biological medicine. Established in 2022, the company operates as both a manufacturer and service provider, employing 11 to 50 people. They focus on developing multi-dimensional intelligent control bioreactors, including small, medium, and large complete sets of process equipment for animal cell large-scale culture, with a particular emphasis on the animal vaccine industry. The company also offers comprehensive technical services for cell culture processes involving bioreactors and collaborates on R&D. Their product categories include Bioreactors, Biological fermenters, Vaccine production facilities, and Animal cell large-scale culture equipment. Jiaxing Keying Intelligent Technology Co., Ltd. is GMP certified and aims to break the monopoly of foreign equipment in the biopharmaceutical industry.
Bioreactor$20000
Jilin Qijian Bio-Pharmaceutical Co., Ltd.
🇨🇳 China
2005201-300 peopleManufacturer/DistributorEstablished brand
High-tech enterprise
OEM manufacturer
Product customization
Shipments
2
Key customer
HEALTH BIOTECH
Key market
North America
Description
Jilin Qijian Bio-Pharmaceutical Co., Ltd. is a national high-tech enterprise and professional manufacturer specializing in the research, development, and production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and drug products. Established in 2005 and headquartered in Changchun, China, the company operates a 30,000 m2 clean workshop and maintains a robust R&D infrastructure led by a team of specialists focused on genetic and enzyme engineering. Their core product portfolio includes Recombinant Human Growth Hormone (HGH), Ademetionine 1,4-Butanedisulfonate (SAM), Monosialotetrahexosylganglioside Sodium (GM1), and Butylphthalide (NBP). The company is a significant player in the biopharmaceutical sector, offering CDMO services and developing biosimilars and small molecule drugs for nervous system, cardiovascular, and metabolic diseases. Jilin Qijian Bio-Pharmaceutical holds multiple quality certifications, including pharmaceutical GMP compliance and US FDA DMF filing (No. 33745) for its HGH raw materials. With a workforce of approximately 200 to 300 employees, the company is highly export-oriented, serving international markets across North America, Europe, Southeast Asia, and the Middle East. Their manufacturing capabilities are supported by four production lines and a commitment to international standards, providing high-quality biological products for the pharmaceutical, healthcare, and cosmetic industries.
Bodybulding$1
